Paul W. Sandman, EVP and General Counsel at BOSTON SCIENTIFIC CORP (BSX), sold 320,000 shares at $15.70 ($5.0M) on 2007-05-01, disclosed to the SEC on 2007-05-03.
Scheduled sale ($5.0M) by EVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.65 | 15,000 | $235K | 4.7% |
| 2 | $15.66 | 17,500 | $274K | 5.4% |
| 3 | $15.68 | 5,000 | $78K | 1.6% |
| 4 | $15.69 | 8,400 | $132K | 2.6% |
| 5 | $15.70 | 29,000 | $455K | 9.0% |
| 6 | $15.71 | 15,500 |
| $244K |
| 4.8% |
| 7 | $15.72 | 8,600 | $135K | 2.7% |
| 8 | $15.73 | 1,200 | $19K | 0.4% |
| 9 | $15.74 | 19,200 | $302K | 6.0% |
| 10 | $15.75 | 43,600 | $687K | 13.6% |
| 11 | $15.76 | 22,000 | $347K | 6.9% |
| 12 | $15.77 | 16,300 | $257K | 5.1% |
| 13 | $15.78 | 21,300 | $336K | 6.7% |
| 14 | $15.79 | 7,900 | $125K | 2.5% |
| 15 | $15.80 | 17,400 | $275K | 5.4% |
| 16 | $15.81 | 15,500 | $245K | 4.9% |
| 17 | $15.82 | 5,800 | $92K | 1.8% |
| 18 | $15.83 | 700 | $11K | 0.2% |
| 19 | $15.84 | 15,100 | $239K | 4.7% |
| 20 | $15.89 | 5,000 | $79K | 1.6% |
| 21 | $15.90 | 5,000 | $80K | 1.6% |
| 22 | $15.93 | 5,000 | $80K | 1.6% |
| 23 | $15.97 | 5,000 | $80K | 1.6% |
| 24 | $15.98 | 2,500 | $40K | 0.8% |
| 25 | $15.99 | 5,800 | $93K | 1.8% |
| 26 | $16.00 | 6,700 | $107K | 2.1% |
| Total | $15.77 avg | 320,000 | $5.0M | 100% |